Prudential Financial’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Prudential Financial’s Portfolio GEVA Stock Details GEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-2,570	Closed	-$251K	–	2306
2015 Q1	$251K	Sell	2,570 -90	-3%	-$9.53K	﹤0.01%	2104
2014 Q4	$247K	Buy	+2,660	New	+$210K	﹤0.01%	2073
2014 Q3	–	Sell	-5,180	Closed	-$543K	–	2413
2014 Q2	$543K	Buy	+5,180	New	+$441K	﹤0.01%	1991
2013 Q3	–	Sell	-13,120	Closed	-$551K	–	2347
2013 Q2	$551K	Buy	+13,120	New	+$598K	﹤0.01%	1914

Prudential Financial's GEVA Position: Q2 2015 in Review

Prudential Financial sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 2,570 shares — an estimated $251K sold.

Prudential Financial first reported a position in GEVA in Q2 2013 and held it in 4 quarters. The position peaked at $551K in Q2 2013. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

Prudential Financial reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
Prudential Financial sold 2,570 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $251K.
Prudential Financial first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q2 2013 and held it in 4 quarters.
Prudential Financial's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $551K in Q2 2013.
0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Prudential Financial's 13F filing for Q2 2015, filed 6 Aug 2015.